The CD1d-Vδ2 bsTCE triggered robust upregulation of the degranulation marker CD107a on both type 1 NKT and Vγ9Vδ2-T cells in co-culture with multiple CD1d+ (but not CD1d−) tumor cell lines with low-nanomolar and low-picomolar EC50s, respectively (Figures 1C–1G). The gene discussed is CD1D; the disease is neoplasm.